My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

Goa Carbon sizzles 63.84% in seven sessions
Jun 21,2017

Meanwhile, the S&P BSE Sensex was down 60.74 points, or 0.19% at 31,236.79. The S&P BSE Small-Cap index was up 60.16 points, or 0.38% at 15,739.88.

High volumes were witnessed on the counter. On the BSE, 6.86 lakh shares were traded on the counter so far as against the average daily volumes of 1.18 lakh shares in the past one quarter. The stock had hit a high of Rs 262.70 so far during the day, which is also its record high. The stock hit a low of Rs 238.90 so far during the day. The stock had hit a 52-week low of Rs 85.10 on 21 November 2016.

The stock had outperformed the market over the past one month till 20 June 2017, advancing 73.31% compared with the Sensexs 2.73% rise. The scrip had also outperformed the market over the past one quarter advancing 124.13% as against the Sensexs 6.03% rise. The scrip had also outperformed the market over the past one year advancing 162.93% as against the Sensexs 16.49% rise.

The small-cap company has equity capital of Rs 9.15 crore. Face value per share is Rs 10.

Shares of Goa Carbon surged 63.84% in seven trading sessions to its current ruling price of Rs 256.50, from a close of Rs 156.55 on 12 June 2017.

Goa Carbons net profit spurted 1139% to Rs 5.08 crore on 13.9% increase in net sales to Rs 76.32 crore in Q4 March 2017 over Q4 March 2016.

Goa Carbon is engaged in the business of manufacturing and marketing of calcined petroleum coke.

Powered by Capital Market - Live News

Amtek Auto surges on buzz of investors interest in stake-buy
Jun 21,2017

Meanwhile, the S&P BSE Sensex was down 77.44 points or 0.25% at 31,220.09. The S&P BSE Small-Cap index rose 53.29 points or 0.34% at 15,733.01.

On the BSE, 18.55 lakh shares were traded on the counter so far as against the average daily volumes of 7.12 lakh shares in the past one quarter. The stock had hit a high of Rs 28.15 and a low of Rs 26.50 so far during the day. The stock had hit a 52-week high of Rs 56.20 on 26 July 2016 and a 52-week low of Rs 21.25 on 20 June 2017.

The stock had underperformed the market over the past one month till 20 June 2017, sliding 30.05% compared with the Sensexs 2.73% rise. The stock had also underperformed the market over the past one quarter, declining 28.09% as against the Sensexs 6.03% rise. The scrip had also underperformed the market over the past one year, declining 28.59% as against the Sensexs 16.49% rise.

The small-cap company has equity capital of Rs 49.65 crore. Face value per share is Rs 2.

Reports suggested that Amtek Auto has received expressions of interest (EoIs) from 21 investors, including Bain Capital, TPG Capital, DA Capital, Piramal Enterprises, AION Capital, Deccan Value Investors and Edelweiss Asset Reconstruction Company which will place financial bids over the next three months for a stake in the debt-ridden auto component maker.

Total promoter holding in Amtek Auto stood at 52.4% as per the shareholding pattern as on 10 April 2017.

Amtek Auto reported net loss of Rs 307.57 crore in Q4 March 2017, lower than net loss of Rs 563 crore in Q4 March 2016. Net sales declined 31.8% to Rs 442.36 crore in Q4 March 2017 over Q4 March 2016.

Amtek Auto is one of the leading integrated auto component manufacturers.

Powered by Capital Market - Live News

Manappuram Finance announces appointment of MD of subsidiary
Jun 21,2017

Manappuram Finance announced the appointment of Jeevandas Narayan as the Managing Director of Manappuram Home Finance, a wholly owned subsidiary of the Company.

Powered by Capital Market - Live News

Alembic Pharma gets healthier after USFDA nod for drug
Jun 21,2017

The announcement was made during market hours today, 21 June 2017.

Meanwhile, the S&P BSE Sensex was down 86.54 points, or 0.28% to 31,210.99.

On the BSE, 3,458 shares were traded in the counter so far, compared with average daily volumes of 56,242 shares in the past one quarter. The stock had hit a high of Rs 545 and a low of Rs 522 so far during the day.

The stock had hit a 52-week high of Rs 709.30 on 23 March 2017. The stock had hit a 52-week low of Rs 517 on 15 June 2017.

The stock had underperformed the market over the past one month till 20 June 2017, falling 12.88% compared with 2.73% rise in the Sensex. The scrip had also underperformed the market in past one quarter, dropping 12.8% as against Sensexs 6.03% gains. The scrip had also underperformed the market in past one year, sliding 0.74% as against Sensexs 16.49% gains.

The large-cap company has equity capital of Rs 37.70 crore. Face value per share is Rs 2.

Alembic Pharmaceuticals announced that the company has received approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application for Candesartan Cilexetil Tablets, 32 mg.

The approved abbreviated new drug application (ANDA) is therapeutically equivalent to the reference listed drug product Atacand Tablets, 32 mg of AstraZeneca Pharmaceuticals LP. The drug is indicated in treatment of hypertension in adults and children and treatment of heart failure.

Candesartan Cilexetil Tablets, 32 mg have an estimated market size of $27 million in US for twelve months ended December 2016, according to IMS.

Alembic Pharmaceuticals consolidated net profit rose 2.4% to Rs 93.04 crore on 18.3% rise in net sales to Rs 741.35 crore in Q4 March 2017 over Q4 March 2016.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, manufactures and markets generic pharmaceutical products all over the world.

Powered by Capital Market - Live News

Zydus receives EIR report for Moraiya manufacturing facility
Jun 21,2017

Zydus Cadilas formulations manufacturing facility at Moraiya, Ahmedabad has received an Establishment Inspection Report from the USFDA signifying the successful closure of the audit. The Moraiya manufacturing plant has completed the USFDA audit from 06 February 2017 to 15 February 2017 with Zero 483 observations. Post the audit, the plant has received several product approvals, including the final approval to market Mesalamine Delayed-Release Tablets USP, 1.2 g in the US.

Powered by Capital Market - Live News

Board of Koa Tools India approves change in company name
Jun 21,2017

Koa Tools India announced the outcome of Board Meeting held on 12 June 2017. It has been decided in the meeting that the company will change its name from Koa Tools India to White & Brooks Industries subject to the name availability from the ROC.

Powered by Capital Market - Live News

Blue Star appoints director
Jun 21,2017

Blue Star has appointed Sam Balsara as an Additional Independent Director with effect from 20 June 2017.

Powered by Capital Market - Live News

Austin Engineering Company announces resignation of company secretary
Jun 21,2017

Austin Engineering Company announced the resignation of Poonam Vijayvargiy as Company Secretary with effect from 20 June 2017.

Powered by Capital Market - Live News

Oracle Financial Services Software allots 13,437 equity shares
Jun 21,2017

Oracle Financial Services Software has allotted 13,437 equity shares under ESOP. With this allotment, the paid up capital of the Company has increased to Rs. 42.64 crore divided into 85,292,400 equity shares of face value of Rs.5/- each.

Powered by Capital Market - Live News

Cadila Healthcare proposes to raise funds through various options
Jun 21,2017

Cadila Healthcare proposes to raise funds through various options. The Board will consider the proposals on 26 June 2017.

Powered by Capital Market - Live News

CG Power advances after accepting binding offer of WEG S.A.
Jun 21,2017

The announcement was made during market hours today, 21 June 2017.

Meanwhile, the S&P BSE Sensex was down 80.13 points, or 0.26%, to 31,217.40. The S&P BSE Mid-Cap index was up 7.83 points, or 0.05%, to 14,853.12.

On the BSE, 1.08 lakh shares were traded in the counter so far, compared with average daily volumes of 5.15 lakh shares in the past one quarter. The stock had hit a high of Rs 87.10 and a low of Rs 84 so far during the day.

The stock had hit a 52-week high of Rs 97.30 on 26 May 2017. The stock had hit a 52-week low of Rs 55.60 on 26 December 2016.

The stock had underperformed the market over the past one month till 20 June 2017, falling 7.47% compared with 2.73% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, gaining 15.22% as against Sensexs 6.03% gains. The scrip had, however, underperformed the market in past one year, gaining 14.67% as against Sensexs 16.49% gains.

The mid-cap company has equity capital of Rs 125.35 crore. Face value per share is Rs 2.

CG Power & Industrial Solutions has accepted a binding offer of WEG S.A. for acquisition of the companys power business in USA comprised in the companys step down overseas subsidiary, CG Power USA Inc. (PSUS), at an enterprise value of $37 million.

In this regard, CG Power Systems Belgium N.V., the companys step down overseas subsidiary has executed a stock purchase agreement on 20 June 2017 with WEG Electric Corp for sale of its 100% stake in PSUS, comprising exclusively of the companys power business at closing.

The SPA is expected to close by 31 July 2017 upon which CG Power USA Inc. will cease to be an overseas subsidiary of the Company.

The deal is part of the companys stated strategy of debt reduction and on focusing on its core operations and core market in India.

WEG SA is a Brazilian company and a global player in electro-electronic products.

On 26 May 2017, the company had said that it received an offer for acquisition of the companys power business in United States of America, comprised in its subsidiary, PSUS. The board decided to divest the power business of PSUS for which the company had constituted a committee to consider the offer and decide on the terms and conditions of acceptance of the offer and closure. The requisite shareholders approval is in place as part of the divestment of the overseas T&D business divestment. The board had mandated the committee to complete the process by 30 June 2017.

CG Power & Industrial Solutions reported consolidated net loss of Rs 444 crore in Q4 March 2017 compared with net loss of Rs 92.90 crore in Q4 March 2016. Net sales fell 7.6% to Rs 1710.06 crore in Q4 March 2017 over Q4 March 2016.

Erstwhile Crompton Greaves, CG Power & Industrial Solutions provides end-to-end solutions, helping its customers use electrical power effectively and increase industrial productivity with sustainability.

Powered by Capital Market - Live News

Alembic Pharmaceuticals gets ANDA approval for Candesartan Cilexetil Tablets
Jun 21,2017

Alembic Pharmaceuticals announced that the Company has received approval from the USFDA for its Abbreviated New Drug Application for Candesartan Cilexetil Tablets, 32 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product Atacand Tablets, 32 mg of AstraZeneca Pharmaceuticals LP. The drug is indicated in treatment of hypertension in adults and children and treatment of heat failure.

Powered by Capital Market - Live News

New orders boost SPML Infra
Jun 21,2017

The announcement was made during market hours today, 21 June 2017.

Meanwhile, the S&P BSE Sensex was down 79.38 points or 0.25% at 31,218.15. The S&P BSE Small-Cap index rose 49.55 points or 0.32% at 15,729.27.

On the BSE, 46,000 shares were traded on the counter so far as against the average daily volumes of 47,348 shares in the past one quarter. The stock had hit a high of Rs 131.60 so far during the day, which is a 52-week high. The stock hit a low of Rs 124.50 so far during the day. The stock had hit a 52-week low of Rs 48.70 on 1 February 2017.

The stock had outperformed the market over the past one month till 20 June 2017, advancing 11.16% compared with the Sensexs 2.73% rise. The stock had also outperformed the market over the past one quarter, surging 105.15% as against the Sensexs 6.03% rise. The scrip had also outperformed the market over the past one year, gaining 96.03% as against the Sensexs 16.49% rise.

The small-cap company has equity capital of Rs 7.33 crore. Face value per share is Rs 2.

The new orders are for irrigation project in Gujarat & Madhya Pradesh, water supply scheme in Jharkhand & power infra development in West Bengal.

SPML Infras net profit surged 238.5% to Rs 11.44 crore on 15% decline in net sales to Rs 467.64 crore in Q4 March 2017 over Q4 March 2016.

SPML Infra is an infrastructure development company.

Powered by Capital Market - Live News

Axis Bank sells stake in Mswipe Technologies
Jun 21,2017

Axis Bank has signed an agreement for sale of 1,90,500 equity shares of face value of Rs. 1 per share of Mswipe Technologies Private Limited, at Rs. 4,249/- per share, resulting in a total cash consideration of Rs. 80.94 crore.

Powered by Capital Market - Live News

PVR opens 5 screen multiplex in Chennai
Jun 21,2017

PVR announced the opening of a 5 screen multiplex at Grand Galada Centre Mall in Chennai. This multiplex is equipped with 2K projection, 7.1 Digital Dolby surround sound system and Dolby ATMOS along with next generation 3-D enabled screen.

With this launch, PVR now operates the largest multiplex network with 584 screens at 127 properties in 50 cities.

Powered by Capital Market - Live News